High‐dose gamma‐globulin therapy in the reactive haemophagocytic syndrome
Authors:
- 1 September 1994
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 88 (1) , 204-206
Abstract
Summary. Reactive haemophagocytic syndrome (RHS) is a disorder characterized by systemic proliferation of non‐malignant histiocytes occuring most commonly in patients with pre‐existing immunological abnormalities or neoplasma. Patients, particularly those with immunosuppression, often have a rapidly progressive fatal course. Treatment is directed at the underlying disorder. In the absence of identifiable cause, the therapy is less satisfactory. We report here three cases of RHS successfully treated with high‐dose gamma‐globulin therapy. Two of the three patients were immunocompromised and the third occurred during pregnancy. The improvement occurred within 24–72 h and all patients recovered. High‐dose i.v. gamma‐globulin therapy may be beneficial in RHS.Keywords
This publication has 8 references indexed in Scilit:
- Hypercytokinemia in Hemophagocytic SyndromeJournal of Pediatric Hematology/Oncology, 1993
- Intravenous immunoglobulin in virus associated haemophagocytic syndrome.Archives of Disease in Childhood, 1990
- THE USE AND MECHANISMS OF ACTION OF INTRAVENOUS IMMUNOGLOBULIN: AN UPDATEBritish Journal of Haematology, 1989
- Hematophagic HistiocytosisMedicine, 1988
- Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studiesBlood, 1985
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982
- Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosisCancer, 1979
- A STUDY OF THE ROLE OF ACUTE INFECTIONS IN PRECIPITATING CRISES IN CHRONIC HEMOLYTIC STATESAnnals of Internal Medicine, 1960